ArticleCureus2025
Diagnostic Challenges of Early Mycosis Fungoides in Skin of Color: A Case Report and Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dupilumab, Asthma, and Lymphoma - Signal or Surveillance Bias?African journal of thoracic and critical care medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycosis fungoides (MF), the most common type of primary cutaneous T-cell lymphoma, presents a formidable diagnostic challenge, particularly in its early stages and in patients with darker skin tones. The initial lesion in this case was diagnosed as cellulitis, a common bacterial skin infection, despite the absence of significant pain, a less typical but documented presentation of cellulitis, which can also manifest as burning, itching, or mere redness and swelling without pronounced tenderness. This case report details the diagnostic journey from initial misdiagnosis to eventual identification of MF in a 57-year-old woman. The report emphasizes the overlapping clinical and histopathological features between MF and more prevalent inflammatory dermatoses, which often lead to diagnostic delays. By including a detailed timeline, comprehensive patient history, explicit diagnostic reasoning, and informed consent declaration, this report aims to highlight the unique barriers to MF diagnosis, especially in individuals with darker skin, and to provide practical insights for clinicians navigating similar diagnostic dilemmas. The rarity and subtlety of early MF, compounded by its ability to mimic benign conditions such as eczema, psoriasis, and cellulitis, underscore the need for heightened clinical suspicion and multidisciplinary collaboration in dermatologic practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.